A Study To Evaluate An Interaction Between Maraviroc And Raltegravir In Healthy Subjects

ViiV Healthcare

Status and phase: Completed; Phase 4

Conditions: Healthy

Treatments: Drug: Maraviroc; Drug: Raltegravir

Study type: Interventional

Funder types: Industry

Identifiers

NCT00666705

A4001082

Details and patient eligibility

About

An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.

Full description

Drug interaction study

Enrollment: 18 patients

Sex: All

Ages: 18 to 55 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy male and/or female subjects between 18 and 55 years of age.

Exclusion criteria

• Evidence or history of clinically significant disease or clinical findings at screening

Trial design

18 participants in 3 patient groups

Maraviroc alone

Experimental group

Treatment:

Drug: Maraviroc

Drug: Maraviroc

Maraviroc + Raltegravir

Experimental group

Treatment:

Drug: Raltegravir

Drug: Raltegravir

Drug: Maraviroc

Drug: Maraviroc

Raltegravir alone

Experimental group

Treatment:

Drug: Raltegravir

Drug: Raltegravir